Incidence of HPVs, EBV, and MMTV-Like Virus in Breast Cancer in Qatar.


Journal

Intervirology
ISSN: 1423-0100
Titre abrégé: Intervirology
Pays: Switzerland
ID NLM: 0364265

Informations de publication

Date de publication:
2022
Historique:
received: 25 11 2021
accepted: 15 04 2022
pubmed: 1 6 2022
medline: 26 10 2022
entrez: 31 5 2022
Statut: ppublish

Résumé

Human papillomaviruses (HPVs), Epstein-Barr virus (EBV), and mouse mammary tumor virus-like virus (MMTV-like virus) can be present and contribute to breast cancer development and progression. However, the role of these oncoviruses and their crosstalk in breast cancer is still unclear. We explored the co-presence of high-risk HPVs, EBV, and MMTV-like virus in 74 breast cancer samples from Qatar using PCR. We found the presence of HPV and EBV in 65% and 49% of our cancer sample cohorts; 47% of the samples are positive for both oncoviruses. The MMTV-like virus alone was detected in 15% of the samples with no significant association with clinicopathological features. The three oncoviruses were co-present in 14% of the cases; no significant association was noted between the co-presence of these viruses and the clinicopathological features. Despite the presence of the oncoviruses, additional studies are necessary to understand their interactions in human breast carcinogenesis.

Identifiants

pubmed: 35640537
pii: 000525277
doi: 10.1159/000525277
pmc: PMC9677861
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

188-194

Informations de copyright

© 2022 The Author(s). Published by S. Karger AG, Basel.

Références

Hum Pathol. 2002 Jun;33(6):608-14
pubmed: 12152159
Cancer Manag Res. 2021 Mar 26;13:2835-2848
pubmed: 33814932
Hum Vaccin Immunother. 2020 Oct 2;16(10):2403-2407
pubmed: 32186955
Cell Adh Migr. 2015;9(5):392-3
pubmed: 26177717
Breast Cancer Res. 2003;5(1):R13-7
pubmed: 12559053
Hum Vaccin Immunother. 2021 Apr 3;17(4):982-989
pubmed: 33006291
PLoS One. 2012;7(11):e48788
pubmed: 23183846
J Exp Med. 2005 Feb 7;201(3):431-9
pubmed: 15684322
J Med Virol. 2010 May;82(6):1044-50
pubmed: 20419820
Breast Cancer Res Treat. 2008 May;109(1):55-8
pubmed: 17624590
Neoplasia. 2006 Mar;8(3):173-80
pubmed: 16611410
Cell. 1982 Nov;31(1):99-109
pubmed: 6297757
Int J Cancer. 2007 Oct 15;121(8):1813-20
pubmed: 17546592
Cancer Lett. 2008 Nov 28;271(2):222-30
pubmed: 18639977
Int J Mol Sci. 2018 Jun 08;19(6):
pubmed: 29890655
Front Oncol. 2018 May 01;8:111
pubmed: 29765906
Lancet Oncol. 2013 Sep;14(10):e417-24
pubmed: 23993386
Infect Agent Cancer. 2014 Nov 10;9:37
pubmed: 25926863
Immunity. 2000 Oct;13(4):497-506
pubmed: 11070168
Mol Clin Oncol. 2015 Mar;3(2):295-298
pubmed: 25798256
Cancer. 2004 Aug 15;101(4):721-6
pubmed: 15305401
Virol J. 2019 Mar 4;16(1):29
pubmed: 30832682
Cancers (Basel). 2020 Mar 10;12(3):
pubmed: 32164347
Int J Mol Sci. 2021 Jul 29;22(15):
pubmed: 34360884
Cancer Cell Int. 2021 Jun 10;21(1):308
pubmed: 34112166
Cell Cycle. 2007 Aug 15;6(16):2038-42
pubmed: 17721085
Nucleosides Nucleotides Nucleic Acids. 2017 Oct 3;36(10):621-630
pubmed: 29185860
Front Oncol. 2018 Jul 02;8:250
pubmed: 30035100
Int J Gynecol Cancer. 2013 Oct;23(8):1423-8
pubmed: 23873177
BMC Cancer. 2018 Feb 9;18(1):170
pubmed: 29426297
Crit Rev Eukaryot Gene Expr. 2016;26(1):27-39
pubmed: 27278883
World J Clin Oncol. 2020 Apr 24;11(4):217-242
pubmed: 32355643
Microb Pathog. 2019 May;130:283-294
pubmed: 30905715
Semin Cancer Biol. 2014 Jun;26:99-115
pubmed: 24751797
Breast Cancer Res. 2005;7(4):171-9
pubmed: 15987472
J Virol. 2006 Nov;80(22):11409-15
pubmed: 16971449
Int J Cancer. 2019 Apr 15;144(8):1941-1953
pubmed: 30350310
Infect Agent Cancer. 2017 Oct 16;12:55
pubmed: 29075317
Oncogene. 2004 Jan 15;23(2):350-8
pubmed: 14724563
Infect Genet Evol. 2017 Oct;54:230-237
pubmed: 28705719
J Exp Clin Cancer Res. 2004 Dec;23(4):561-6
pubmed: 15743024
Future Microbiol. 2006 Jun;1(1):33-51
pubmed: 17661684
Pathogens. 2020 Jun 08;9(6):
pubmed: 32521661
Science. 1936 Aug 14;84(2172):162
pubmed: 17793252
Int J Environ Res Public Health. 2020 Dec 18;17(24):
pubmed: 33352945
Cancer Cell Int. 2020 Aug 03;20:361
pubmed: 32774155
Breast Cancer (Auckl). 2020 Nov 24;14:1178223420976388
pubmed: 33281452
Cancer Res. 1989 Jul 15;49(14):3879-83
pubmed: 2544262
Cancers (Basel). 2010 Apr 30;2(2):752-72
pubmed: 24281093
Am J Transl Res. 2014 May 15;6(3):248-66
pubmed: 24936218
Front Oncol. 2020 Aug 20;10:1016
pubmed: 32974123
Chin J Cancer. 2016 Jan 22;35:16
pubmed: 26801987
Breast Cancer (Dove Med Press). 2021 Jan 08;13:21-30
pubmed: 33447078
Hum Vaccin Immunother. 2016 Jul 2;12(7):1936-9
pubmed: 27082145

Auteurs

Ishita Gupta (I)

College of Medicine, QU Health, Qatar University, Doha, Qatar.

Reem Al-Sarraf (R)

Department of Pathology, Hamad General Hospital, Doha, Qatar.

Hanan Farghaly (H)

Department of Pathology, Hamad General Hospital, Doha, Qatar.

Semir Vranic (S)

College of Medicine, QU Health, Qatar University, Doha, Qatar.

Ali A Sultan (AA)

Department of Microbiology and Immunology, Weill Cornell Medicine - Qatar, Doha, Qatar.

Hamda Al-Thawadi (H)

College of Medicine, QU Health, Qatar University, Doha, Qatar.

Ala-Eddin Al Moustafa (AE)

College of Medicine, QU Health, Qatar University, Doha, Qatar, aalmoustafa@qu.edu.qa.
Biomedical Research Centre, Qatar University, Doha, Qatar, aalmoustafa@qu.edu.qa.

Halema F Al-Farsi (HF)

College of Medicine, QU Health, Qatar University, Doha, Qatar.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH